Billiontoone (NASDAQ:BLLN) Hits New 12-Month High – Still a Buy?

Billiontoone, Inc. (NASDAQ:BLLN) shares hit a new 52-week high on Thursday . The stock traded as high as $138.89 and last traded at $137.69, with a volume of 365410 shares traded. The stock had previously closed at $132.52.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Weiss Ratings upgraded Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. Guggenheim initiated coverage on Billiontoone in a report on Monday, June 29th. They issued a “buy” rating and a $125.00 price target for the company. JPMorgan Chase & Co. increased their target price on Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Finally, BTIG Research dropped their target price on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Six analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Billiontoone presently has a consensus rating of “Moderate Buy” and a consensus target price of $126.00.

Billiontoone Stock Down 0.7%

The company has a market capitalization of $6.37 billion and a price-to-earnings ratio of 252.00. The company has a current ratio of 10.92, a quick ratio of 10.58 and a debt-to-equity ratio of 0.18. The firm’s fifty day simple moving average is $113.36 and its two-hundred day simple moving average is $93.29.

Billiontoone (NASDAQ:BLLN) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.33. The business had revenue of $108.39 million for the quarter, compared to analysts’ expectations of $95.81 million. The business’s revenue for the quarter was up 83.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.39) earnings per share. Sell-side analysts anticipate that Billiontoone, Inc. will post 0.92 EPS for the current year.

Insider Buying and Selling at Billiontoone

In other Billiontoone news, CTO David Tsao sold 20,000 shares of the firm’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $102.27, for a total value of $2,045,400.00. Following the sale, the chief technology officer directly owned 1,000 shares in the company, valued at $102,270. This trade represents a 95.24% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nancy Joann Johnson sold 10,582 shares of the stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $100.47, for a total transaction of $1,063,173.54. Following the completion of the transaction, the insider owned 21,900 shares in the company, valued at $2,200,293. This represents a 32.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 153,049 shares of company stock worth $16,768,021. 50.22% of the stock is currently owned by insiders.

Institutional Trading of Billiontoone

Several institutional investors and hedge funds have recently bought and sold shares of BLLN. Adams Street Partners LLC purchased a new stake in Billiontoone during the 4th quarter valued at approximately $140,063,000. Baillie Gifford & Co. acquired a new stake in Billiontoone in the fourth quarter valued at about $103,786,000. Wasatch Advisors LP raised its stake in shares of Billiontoone by 40.2% during the 2nd quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock worth $62,160,000 after buying an additional 148,446 shares in the last quarter. Price T Rowe Associates Inc. MD acquired a new position in Billiontoone during the fourth quarter worth $39,717,000. Finally, JPMorgan Chase & Co. acquired a new position in shares of Billiontoone during the 4th quarter worth $32,078,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.